Biogen proposes to buy remaining stake in Sage
Drugmaker Biogen will buy all outstanding shares of Sage Therapeutics that it does not already… Read More
7 months ago
Biogen
Leqembi: Alzheimer’s drug from Eisai and Biogen faces setback
The European Union's drugs regulator has rejected Eisai and Biogen's Leqembi treatment for early Alzheimer's… Read More
1 year ago
Charity to pay $4 million to resolve pharma kickback probe
A charity will pay $4 million to resolve claims that it acted as a conduit… Read More
6 years ago